Related Experiment Video

Updated: Aug 12, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Newcastle disease virus (NDV): brief history of its oncolytic strains

J G Sinkovics1, J C Horvath

  • 1Cancer Institute, St. Joseph's Hospital, and The University of South Florida College of Medicine, Tampa 33607, USA. jsinkovi@com1.med.usf.edu

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|February 19, 2000
PubMed
Abstract

Insights

Newcastle disease virus (NDV) shows strong oncolytic activity for cancer therapy. NDV oncolysates are recommended for immunotherapy over live virus strains, especially when pre-clinical testing confirms oncolytic efficacy.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Naturally occurring viruses exhibit potent oncolytic activity against cancers.
  • Newcastle disease virus (NDV) is a prominent example of an effective oncolytic agent.

Purpose of the Study:

  • To explore the potential of Newcastle disease virus (NDV) as an oncolytic agent.
  • To investigate methods for developing or selecting highly oncolytic NDV strains with reduced toxicity.

Main Methods:

  • Examining mechanisms of viral oncolysis.
  • Evaluating tests to predict NDV oncolytic activity.
  • Assessing optimal administration methods for oncolytic effects.
  • Utilizing NDV oncolysates for immunotherapy, drawing parallels with other viral therapies.

Main Results:

  • NDV demonstrates significant oncolytic potential.
  • Oncolysates may offer advantages over live virus administration.
  • Pre-clinical validation of oncolytic activity is crucial.

Conclusions:

  • NDV oncolysates are likely superior for immunotherapy, inducing tumor-specific immunity.
  • This approach is preferable to repeated administration of unverified NDV strains.
  • Careful strain selection and pre-clinical testing are essential for effective NDV-based cancer therapy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on: May 25, 2022

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...